FDA approves Genentech’s Vabysmo Prefilled Syringe (PFS) for three leading causes of vision loss BusinessWire Jul 5, 2024 Vabysmo PFS is reportedly the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal…
